MillerKnoll is rated Hold with its current stock price of $20.80 reflecting the base case scenario and offering limited upside potential. The company's FY27 guidance suggests only modest margin improvements, with earnings growth mainly driven by tax and financing factors rather than core business operations. Key segments like Global Retail and International have underperformed FY26 targets, and no significant recovery is expected in FY27. Investors are advised to watch for margin improvements in Global Retail, stabilization in International orders, and backlog trends for any potential upgrades in outlook.
MillerKnoll's recent financial performance provides context for this market snapshot. For readers following consumer cyclical stocks, here is Pluang's market snapshot as of Sep 15, 2026 20:04 WIB: Out of 105 priced US Consumer Cyclical-sector stocks tradable on Pluang, 26 rose and 69 fell today. Notable movers include Trip.com Group Ltd (TCOM) at USD 39.85 with a 1-day change of +1.97%, Firy Inc. (FIRY) at USD 10.10 down -1.94%, and DoorDash Inc (DASH) at USD 200.88 down -1.31%.
WasabiCard, a stablecoin-based global payment provider, engaged in key partnership discussions at TOKEN2049 Singapore 2026, focusing on white-label card issuing, global payouts, and embedded payments. The company highlighted growing demand in APAC fo...
The global next generation antibody therapeutics market is projected to increase from $5.45 billion in 2026 to $5.76 billion by 2035, growing at a CAGR of 1%. Growth is fueled by advances in biotechnology, rising demand for targeted therapies, and in...
The global insurtech market is projected to grow from $14 billion today to $638 billion by 2035, at a compound annual growth rate of 41.45%. This rapid expansion is fueled by the adoption of AI, blockchain, cloud computing, machine learning, IoT, and...
The global market for wiring harnesses and connectors in electric vehicles is projected to grow from $8.53 billion in 2025 to $29.43 billion by 2035, at a CAGR of 12.83%. This growth is fueled by increasing EV production, adoption of battery electric...
The global Decentralized Clinical Trials (DCT) market, valued at $8.8 billion in 2025, is projected to grow to $18.8 billion by 2030, expanding at a CAGR of 13.7%. Growth is fueled by adoption of AI, wearables, cloud platforms, and flexible remote st...
